Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Multi-drug-resistant tuberculosis Stories

2008-08-06 18:00:38

Extensively drug-resistant tuberculosis, or XDR-TB, can be commuted in an individualized outpatient therapy program, researchers in Peru said. The study, conducted in Peru from 1999 to 2002, showed that more than 60 percent of XDR-TB patients not co-infected with HIV were cured after receiving the bulk of their personalized treatment at home or in community-based settings. Lead author Carole Mitnick of the Harvard Medical School said that in some parts of the world, however, patients...

2008-07-22 09:00:00

The World Health Organization (WHO) on Monday said Asian nations had failed to rein in the rapid growth of highly lethal, drug-resistant strains of tuberculosis ( TB) and warned that the disease could soon become a serious threat to the region as a whole. Only one percent of the estimated 150,000 people with multi- drug- resistant tuberculosis (MDR-TB) in WHO's Western Pacific Region, which covers East Asia and the Pacific, are getting appropriate treatment, the Manila-based WHO regional...

2008-07-04 03:00:06

By Schofield, Cynthia B Smallpox, diphtheria, typhoid fever, polio, cholera, and tuberculosis (TB) are among the diseases that struck fear into citizens of 18th- and 19th-century America. Discovery of antibiotics and antiseptic techniques in 20th-century America made the threat of death from an infectious disease seem like a horror of the past. In 1882, Robert Koch isolated and identified the Mycobacterium tuberculosis (MTB) bacillus, followed by Vibrio cholerae a year later. Louis Pasteur,...

2008-07-02 06:00:14

By DeRiemer, Kathryn De Jong, Bouke C The estimated 9.2 million new cases of tuberculosis (TB) and 1.7 million annual deaths from TB during 2006 are a bleak reminder that new, creative strategies are needed to prevent and controlTB worldwide (1). For the past 15 years, molecular epidemiologic techniques have been used to identify clusters of TB cases whose isolates have identicalDNAfingerprints or genotypes, indicating recent transmission of Mycobacterium tuberculosis (2). In this issue of...

2008-07-02 00:00:06

By Kounteya Sinha NEW DELHI: Diagnosing multi drug-resistant tuberculosis (MDR-TB) will now take just two days' time. In a major announcement on Monday, the World Health Organisation decided to make widely available a path-breaking rapid molecular diagnostic tool that will generate TB test results in two days flat. Currently, standard tests take up to three months. This is why only 2% of MDR-TB cases worldwide are being diagnosed and treated appropriately. Speaking to TOI from...

2008-07-01 09:00:04

By FRANK JORDANS By Frank Jordans The Associated Press GENEVA A new test to quickly diagnose drug-resistant forms of tuberculosis will be rolled out in four African countries this year, the World Health Organization said Monday. The DNA-based test will cut the time it takes to detect multi- drug resistant TB from up to four months to a matter of hours, the director of WHO's tuberculosis program said . Dr. Mario Raviglione said testing is currently "one of the major bottlenecks"...

2008-07-01 06:00:04

By Steve Sternberg Rapid DNA tests that can save thousands of lives by cutting delays in diagnosis of drug-resistant tuberculosis from two months to two days will be rolled out in 16 countries fighting twin epidemics of HIV and TB, health officials said Monday. Current TB tests are more than a century old. The new tests, which apply DNA "fingerprinting" techniques to TB for the first time, mean that patients who show evidence of TB infection can now be tested and treated quickly rather...

2008-06-24 12:03:10

The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) announced today a five-year research collaboration designed to yield new medicines for TB, including drug-resistant TB. The partnership is a milestone toward the development of faster TB drug regimens that treat all forms of TB, are easier for patients to complete, and can be used safely in patients with HIV/AIDS. "Since the NITD's establishment in 2002, its core strategy has...

2008-06-17 03:00:10

By Chang, Kwok C Leung, Chi C; Yew, Wing W; Lau, Tat Y; Tam, Cheuk M Rationale: Relatively little is known about the hepatotoxicity of pyrazinamide. Objectives: We compared continuation-phase regimens incorporating pyrazinamide, isoniazid, and/or rifampin with those containing isoniazid and rifampin to evaluate the hepatotoxicity of pyrazinamide. Methods: Cohort and nested case-control analyseswere conducted on a cohort of 3,007 patients with active tuberculosis (TB) managed at government...

2008-06-17 03:00:10

By Cohen, Ted Colijn, Caroline; Wright, Abigail; Zignol, Matteo; Pym, Alexander; Murray, Megan The International Union Against Tuberculosis and Lung Disease/ World Health Organization Global Project on Anti-Tuberculosis Drug Resistance Surveillance recently released the fourth global survey, which documents the highest burden of multidrug-resistant tuberculosis (TB) yet reported. The best estimate of the number of new cases of multidrug-resistant disease occurring in 2006 is close to half a...